CASP3 and ovarian carcinoma: There were no differences in apoptosis (assessed by cleaved caspase 3 positivity) in the four different ovarian cancer tissues treated with either CD3 or a 1:1 mix of CD4:CD8 nfP2X7 CAR‐T cells (Supplementary figure 4b–e).